New Therapies in RA Management

PRESENTER: Amanda Mixon, PA-C
Arthritis and Rheumatology Clinic of Northern Colorado
Fort Collins, CO

Credits: 0.25

Release Date: July 01, 2019

Expiration Date: June 30, 2020

*This program has expired. CME credit is no longer available.

TO PARTICIPATE AND CLAIM CREDIT: View the internet based webcast via up to date browser. Achieve a 70% passing grade on post-test. Complete and return Evaluation/Request for Credit Form. Certificate of Credit or Participation may be printed at completion and will also be sent via email.

Target Audience:This activity has been designed to meet the educational needs of rheumatologists, physician assistants, and nurse practitioners involved in the care of patients with rheumatoid arthritis (RA).

Learning Objectives: After the completion of this activity, participants should be able to:

  • Describe their indications for the treatment of rheumatoid arthritis
  • Summarize their potential adverse effects
  • Synthesize clinical trial data on their use in the treatment of rheumatoid arthritis
  • AAPA:
    This activity has been reviewed by the AAPA Review Panel and is compliant with AAPA CME Criteria. This activity is designated for a maximum of 2.5 AAPA Category 1 CME credits. Approval is valid for one year from 07/01/2019. PAs should only claim credit commensurate with the extent of their participation.

    This activity is approved for 0.25 contact hour(s) of continuing education by the American Association of Nurse Practitioners. Activity ID 19063743. This activity was planned in accordance with AANP Accreditation Standards and Policies.

    Disclosure Statement: All faculty AND staff involved in the planning, review or presentation of continuing education activities sponsored/provided by Purdue University College of Pharmacy are required to disclose to the audience any relevant commercial financial affiliations related to the content of the presentation or enduring material. Full disclosure of all commercial relationships must be made in writing to the audience prior to the activity.

    All additional planning committee members, reviewers and Purdue University College of Pharmacy and Focus Medical Communications staff have no relationships to disclose.

    STATEMENT OF SUPPORT: This activity is supported by educational grants from Amgen, Janssen, Lilly and Novartis.

    Amanda Mixon, PA-C
    Amanda Mixon has been an advisory board member for AbbVie, Celgene, Novartis, Regeneron and Sandoz. She has also received honorarium from AbbVie, Celgene, Novartis, Regeneron and Sandoz.